Sugarlogix was found in 2016 and manufactures complex sugars found within human breast milk that have probiotic functions using biologically engineered yeast. The complex sugars made by Sugarlogix are made to selectively feed bacteria found within the human gut biome that help restore ratios of bacteria within the gut that promote better health.
Co-founder and CSO of Sugarlogix Kulika Chomvong explains the technology and purpose behind Sugarlogix.
Funding
Seed
On May 3, 2017 concluded a seed funding round and raised an undisclosed sum of money from Indie Bio and SOSV.
Products
2-Fucosyllactose (2-FL)
The first product Sugarlogix is commercializing is 2-Fucosyllactose (2-FL), a prebiotic protein that is found only in human breast milk. The company secured FDA approval for their 2-FL, and have plans to begin shipping in 2018.
Timeline
Seed Funding
On May 3, 2017 concluded a seed funding round and raised an undisclosed sum of money from Indie Bio and SOSV.
People
Chaeyoung Shin
David E. Weekly
Investor
Jamie Cate
Jason Liu
Kulika Chomvong
Steve Pietsch
Yong-Su Jin
Further reading
Berkeley's Sugarlogix is engineering a sugar that's good for you
Cirrus Wood
Sugarlogix: Prebiotic Sugar for Your Gut Health - IndieBio
Kayla Liederbach
The Latest Healthy Sugar Is Made from Human Breast Milk
Hillary Eaton
The Next Thing In Gut Health Is Going To Be Sugar Made From Human Breast Milk
Adele Peters
Documentaries, videos and podcasts
Sugarlogix: making healthy sugars that are worth the addiction
December 5, 2017
Companies
Company
Food technology
Food industry
Nutrition
Synthetic biology
Berkeley, California
Jamie Cate
Kulika Chomvong
Chaeyoung Shin
IndieBio
